Press Release
Press Release
Press Contacts: Erik Cummins, Matt Hyams, Taina Rosa, Olivia Thomas
02.26.25
A team of Pillsbury lawyers led by Corporate partner Patrick Devine and counsel Christian Holbrook advised HealthQuest Capital, a private asset firm that provides capital to transformative healthcare companies, in leading a $142 million equity financing for premier organ medical technology company OrganOx Ltd. as a new investor.
The OrganOx metra® is a normothermic machine perfusion (NMP) platform technology that has been utilized in over 5,000 liver transplants to date, approved in the U.S., Europe, Canada and Australia. According to a company press release, the NMP keeps donor livers in a metabolically active state outside the body, providing transplant teams the opportunity for functional assessment of the organ prior to transplant and leads to an increased number of organs available for transplant.
Click here to learn more.
In addition to Devine and Holbrook, the Pillsbury deal team included Corporate partners Nick Burgess and Richard Blaylock and associates Kate Chan, Sheetal Misra and Isabella Borges; Executive Compensation & Benefits partner Jessica Lutrin and associate Ryan Kenny; Employment Law partner Rebecca Carr Rizzo, associate Laura Killalea and consultant Robert Davies; and Tax partner Brett Willis and consultant John McLean.